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Current serotyping methods classify Pasteurella multocida into five capsular serogroups (serogroups A, B, D,
E, and F) and 16 somatic serotypes (serotypes 1 to 16). In the present study, we have developed a multiplex PCR
assay as a rapid alternative to the conventional capsular serotyping system. The serogroup-specific primers
used in this assay were designed following identification, sequence determination, and analysis of the capsular
biosynthetic loci of each capsular serogroup. The entire capsular biosynthetic loci of P. multocida A:1 (X-73)
and B:2 (M1404) have been cloned and sequenced previously (J. Y. Chung, Y. M. Zhang, and B. Adler, FEMS
Microbiol. Lett. 166:289–296, 1998; J. D. Boyce, J. Y. Chung, and B. Adler, Vet. Microbiol. 72:121–134, 2000).
Nucleotide sequence analysis of the biosynthetic region (region 2) from each of the remaining three serogroups,
serogroups D, E, and F, identified serogroup-specific regions and gave an indication of the capsular polysac-
charide composition. The multiplex capsular PCR assay was highly specific, and its results, with the exception
of those for some serogroup F strains, correlated well with conventional serotyping results. Sequence analysis
of the strains that gave conflicting results confirmed the validity of the multiplex PCR and indicated that these
strains were in fact capsular serogroup A. The multiplex PCR will clarify the distinction between closely related
serogroups A and F and constitutes a rapid assay for the definitive classification of P. multocida capsular types.
Pasteurella multocida is a heterogeneous species that pro-
duces septicemic or respiratory diseases in domesticated and
wild animals (12). Considerable variation has been observed
among strains with respect to host predilection, pathogenicity,
carbohydrate fermentation, colonial morphology, and anti-
genic specificity (6). Serological differences were also observed
in the type-specific capsular antigen of P. multocida identified
by Carter (4). This resulted in the development of the indirect
hemagglutination test, which now recognizes five distinct cap-
sular serogroups (serogroups A, B, D, E, and F) (12).
Until recently, little was known of the composition of cap-
sular material from P. multocida serogroups other than that of
serogroup A, which is known to be sensitive to the action of
hyaluronidase (3, 5). Nuclear magnetic resonance studies con-
firmed that the major polysaccharide component of the capsule
was hyaluronic acid (13). The capsular material of serogroups
D and F has been identified primarily through the action of
mucopolysaccharidases (11). On the basis of the decapsulation
profiles of P. multocida by these enzymes, it was proposed that
serogroups D and F produced capsular material that contained
heparin and chondroitin sulfate, respectively (11). The produc-
tion of a chondroitin or chondroitin-like polysaccharide cap-
sule by P. multocida serogroup F was recently confirmed by
carbohydrate analysis (9). The monosaccharide analysis of a
serogroup B P. multocida strain determined that the purified
capsular polysaccharide was composed of arabinose, mannose,
and galactose in a ratio of 0.5:2.0:0.8 (N. Muniandy, J. Edgar,
J. B. Woolcock, and T. K. S. Mukkur, Int. Workshop Pasteu-
rellosis Prod. Anim., 1992). The chemical composition of the
serogroup E capsule remains unknown.
The biosynthetic loci of the complete capsules of P. multo-
cida serotypes A:1 (7) and B:2 (1) have recently been identi-
fied, with gene identification within the serogroup-specific re-
gion 2 of both loci supporting previous data regarding capsule
composition. Two genes within this region of the B:2 locus,
bcbA and bcbB, were similar to Escherichia coli wecB and wecC,
which catalyze the conversion of UDP-N-acetylglucosamine to
N-acetyl-D-mannosaminuronic acid (1). The presence of these
homologs in the serogroup B cap locus suggests that the man-
nose identified as the major type B capsular component by
Muniandy et al. (Int. Workshop Pasteurellosis Prod. Anim.)
exists as N-acetyl-D-mannosaminuronic acid in situ (1). Region
2 has also been partially cloned and sequenced from serogroup
F, with the identification of a glycosyltransferase involved in
elongation of chondroitin polymers (9). A detailed review of
the composition, function, and genetics of the P. multocida A:1
and B:2 capsules has recently been published (2).
The lack of genetic knowledge regarding the capsular ma-
terial of serogroups D, E, and F and the increasing need for a
simple, DNA-based capsular typing method provided the im-
petus for the investigation described here. Oligonucleotide
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primers designed during sequencing of the biosynthetic loci of
the capsules of serogroups A and B (1, 7) were used to deter-
mine the nucleotide sequences of the region 2 genes from the
remaining three capsular serogroups (serogroups D, E, and F).
Serogroup-specific sequences were then identified for use as
primers in a multiplex PCR assay. This assay represents a rapid
and reproducible alternative to the serological and nonsero-
logical methods currently used for the classification of P. mul-
tocida capsular types.
MATERIALS AND METHODS
Bacteria. The P. multocida strains used in this study are described in Table 1.
The P. multocida isolates from the Veterinary Pathology Laboratory were sero-
typed by the Veterinary Research Institute, Peradeniya, Sri Lanka. All other
P. multocida serotype designations were determined by the National Animal
Disease Center (NADC), Ames, Iowa (R. B. Rimler and K. A. Brogden, per-
sonal communication), or from previous publications (6, 10, 15).
PCR primers. All primers used in the study either were synthesized by Life
Technologies (Gaithersburg, Md.) or Genset Pacific (Lismore, New South Wales,
Australia) or were previously synthesized for sequence determination of the
P. multocida A:1 and B:2 cap loci (1, 7). The primer sequences used in the
multiplex P. multocida capsular typing PCR assay are listed in Table 2.
PCR conditions. Initial PCR amplification was carried out with single primer
sets from within the region 2 genes of the serogroup A and B capsule biosynthetic
loci. For ease and rapidity, whole cells obtained from single colonies grown on
8% sheep blood agar were used as the template in the amplification reactions. A
pipette tip was lightly touched onto a bacterial colony, and the colony was
resuspended in the PCR amplification mixture (25 ml) containing each primer at
a concentration of 3.2 mM, each deoxynucleoside triphosphate at a concentration
of 200 mM, 13 PCR buffer, 2 mM MgCl2, and 0.5 U of Taq DNA polymerase
(Gibco BRL Life Technologies). All amplifications were performed with the
GeneAmp PCR system 2400 (Perkin-Elmer, Branchburg, N.J.). For products
with an expected size of #1 kb, the following standard cycling procedure was
used: an initial denaturation at 95°C for 5 min, followed by 30 cycles of dena-
turation at 95°C for 30 s, annealing at 55°C for 30 s, extension at 72°C for 30 s,
and a final extension at 72°C for 5 min. The same cycling procedure was used for
products of an expected size between 1 and 3 kb, except that the extension time
was increased by 30 s for each additional 1 kb.
Long-template ($3 kb) amplification used for sequence analysis of the region
2 genes from serogroups D, E, and F was performed with the ELONGASE
Enzyme Mix (Gibco BRL Life Technologies).
Restriction endonuclease analysis of regions demonstrating similarity be-
tween serogroups. PCR-restriction fragment length polymorphism analysis was
performed on regions 1 and 3 of the cap loci from reference type strains of all five
capsular serogroups. These regions were amplified with the ELONGASE Enzyme
Mix (Gibco BRL Life Technologies) and oligonucleotide primers from sero-
group A and B cap loci. The PCR products were then purified with the QIAquick
PCR purification kit (QIAGEN Pty. Ltd., Clifton Hill, Victoria, Australia) and
digested with a restriction enzyme, BamHI, EcoRI, EcoRV, HhaI, HindIII, PstI,
or Sau96-I. Digestion products were visualized following agarose gel electro-
phoresis.
Determination of nucleotide sequences of region 2 genes of serogroups D, E,
and F. Strains P934 (serogroup D), P1234 (serogroup E), and P4218 (serogroup
F) were used to determine the nucleotide sequences of the region 2 genes from
the cap loci of serogroups D, E, and F. Following long-template amplification,
the PCR products were purified with QIAquick PCR purification kit (QIAGEN)
and cloned into the pGEM-T Easy Vector (Promega, Madison, Wis.) for se-
quence analysis. Nucleotide sequences were determined with the BigDye Ready
Reaction DyeDeoxy Terminator Cycle Sequencing Kit (Perkin-Elmer, Foster
City, Calif.), and the reactions were analyzed with a 373A DNA sequencing
system at the Australian Genome Research Facility, Brisbane, Queensland,
Australia.
Development of a multiplex PCR assay for capsular serogroup identification.
Following sequence determination and analysis of P. multocida capsular sero-
group-specific regions, a multiplex PCR assay was developed that contained P.
multocida-specific primers (14) and primer sets specific for serogroups A, B, D,
E, and F. The serogroup-specific primer sets were identified according to the
following criteria: (i) primer sets were to be located within genes established as
unique for each of the five serogroups (hyaD, bcbD, dcbF, ecbJ, and fcbD), and
(ii) amplimer length was sufficient to allow clear size discrimination. The multi-
plex PCR mixture contained each primer within the six primer sets at a concen-
tration of 3.2 mM, 1 U of Taq DNA polymerase, 2 mM MgCl2, each deoxynucleo-
side triphosphate at a concentration of 200 mM, and 13 PCR buffer. A standard
cycling program was used, as described above. The amplified products were
separated by electrophoresis in 2% agarose gels and visualized by ethidium
bromide staining.
Nucleotide sequence accession numbers. The GenBank accession numbers for
the region 2 cap loci sequences are as follows: serogroup D (strain P934),
AF302465; serogroup E (strain P1234), AF302466; and serogroup F (strain
P4218), AF302467.
RESULTS
Genetic organization of P. multocida capsular biosynthetic
loci. The genetic organization of cap loci from P. multocida
serogroups A:1 and B:2 has been established previously. We
have found a high level of similarity between serogroups A, D,
TABLE 1. History and origin of P. multocida strains used to




PCR result with the
following primer sets
CAPA CAPB CAPD CAPE CAPF
X-73 (A:1)a Heddleston type 1 ref-
erence, chicken
1 2 2 2 2
P1201 (A)a Carter type A refer-
ence, fowl
1 2 2 2 2
P5228 (A:1)b United States, duck 1 2 2 2 2
P5229 (A:1)b United states, duck 1 2 2 2 2
P5338 (A:1)b United states, turkey 1 2 2 2 2
P5339 (A:1)b United states, turkey 1 2 2 2 2
VP161 (A:1)c Vietnam, chicken 1 2 2 2 2
VP21 (A:3)c Australia, chicken 1 2 2 2 2
VP17 (A:4)c Australia, chicken 1 2 2 2 2
M1404 (B:2)a Heddleston type 2 ref-
erence, buffalo
2 1 2 2 2
P932 (B)a Carter type B refer-
ence, buffalo
2 1 2 2 2
VP247 (B:2)c Vietnam, pig 2 1 2 2 2
0140 (B:3,4)d Australia cattle 2 1 2 2 2
P1511 (B:1)a United States, antelope 2 1 2 2 2
P5226 (B:4)a Canada, bison 2 1 2 2 2
P5325 (B:3,4)a United states, elk 2 1 2 2 2
P934 (D)a,e Carter type D refer-
ence, pig
2 2 1 2 2
P903 (D:11)a Heddleston type 11
reference, pig
2 2 1 2 2
VP96 (D:1)c Australia, pig 2 2 1 2 2
VP366
(D:3,4)c
Vietnam, pig 2 2 1 2 2
VP381 (D:1)c Vietnam, pig 2 2 1 2 2
0148 (E)d South Africa, cattle 2 2 2 1 2
0149 (E)d Africa, cattle 2 2 2 1 2
0150 (E)d Africa, cattle 2 2 2 1 2
P1234(E)a,e Carter type E refer-
ence, cattle
2 2 2 1 2
P1235 (E)a Africa, Carter type E 2 2 2 1 2
P4218 (F:3)a,e United states, turkey 2 2 2 2 1
P4988 (F:1)b United States, deer 1 2 2 2 2
P5239 (F:1)b United States, swine 1 2 2 2 2
P5184 (F:3,4)b United States, sheep 1 2 2 2 2
P5084 (F:14,
15,12)b
United States, turkey 2 2 2 2 1
a Obtained from K. R. Rhoades and R. B. Rimler, NADC.
b Obtained from K. A. Brogden, NADC.
c Isolates held in the Veterinary Pathology Culture Collection, University of
Queensland.
d Originally obtained from Regional Veterinary Laboratory, Benalla, Victoria,
Australia.
e Strains were used to sequence the region 2 genes of the cap loci from
serogroups D, E, and F.
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and F, with positive reactions obtained with most primers
throughout the P. multocida A:1 cap locus, while no amplimers
were produced from serogroups B and E (data not shown).
Primers specific for hyaC-hyaE (region 2) showed some varia-
tion in amplification of serogroups D and F, while PCR-re-
striction fragment length polymorphism analysis of the region
1 genes from serogroups A, D, and F demonstrated identi-
cal restriction profiles with BamHI, EcoRI, EcoRV, HhaI,
HindIII, PstI, and Sau96-I (data not shown).
The majority of primers from the P. multocida B:2 cap locus
also amplified DNA from serogroup E but not DNA from
serogroup A, D, or F (data not shown). The amplification
profiles also showed that while homologs of bcbI, bcbB, and
bcbA were present in the serogroup E cap locus, a lower degree
of similarity was observed in the intervening genes, with no am-
plimers demonstrated when primers specific for bcbCDEFGH
were used.
Amplification of DNA across the cap regions indicated that
P. multocida serogroups A, D, and F possess similar organiza-
tions, comprising region 1 (capsule export; hexDCBA homo-
logs), region 2 (capsule biosynthesis), and region 3 (phospho-
lipid substitution; lipA and lipB homologs) (Fig. 1). As shown
previously, P. multocida serogroup B:2 demonstrates some re-
assortment of region 1 and 3 genes, with lipA found to be co-
transcribed with cexDCBA. Initial amplification studies and
sequence determination showed a similar organization within
the serogroup E cap locus (Fig. 1). The .99% identity of
sequences flanking the cap loci of serogroups A and B was also
demonstrated in the other three serogroups, suggesting a com-
mon chromosomal location for the cap loci of all serogroups.
Analysis of region 2 genes of serogroups D, E, and F. In
order to define further the genetic organization of the P. mul-
tocida cap loci, the region 2 genes from capsular serogroups D,
E, and F were cloned and sequenced. Predicted genes from
these regions were designated dcb, ecb, and fcb for serogroup
D, E, and F capsule biosynthesis, respectively. Whenever pos-
sible, the letter designation was maintained between serogroup
homologs. Open reading frame (ORF) sizes and homolog sim-
ilarities between serogroups A, D, and F are shown in Table 3,
with the similarities between the region 2 genes of serogroups
B and E listed in Table 4.
Region 2 of serogroup D was shown to contain four genes,
dcbEFCB, in the same orientation as hyaEDCB of A:1 (Fig. 1).
DcbB and DcbC are homologs of HyaB and HyaC, respec-
tively, with 98 and 92% similarities, respectively (Table 3). The
501-amino-acid product of dcbF displayed no similarity to
HyaD of P. multocida A:1 but showed some similarity to bac-
terial glycosyltransferases (Table 5). In particular, DcbF has
54% similarity to the putative glycosyltransferase KfiC from
the Escherichia coli K5 capsule biosynthetic locus. The de-
duced product of dcbE demonstrated 56% similarity to HyaE,
although DcbE (603 amino acids) is slightly shorter than HyaE
(622 amino acids) (Table 3).
The capsule biosynthesis genes of serogroup F showed sig-
nificant similarity to those of P. multocida A:1, with the prod-
ucts of fcbB, fcbC, and fcbE exhibiting identical lengths and
.97% similarities to their A:1 homologs (Table 3). The de-
duced product of fcbD was determined to have 90% similarity
to HyaD (A:1) and pmHAS (8). In addition, FcbD had 97%
similarity to the chondroitin synthase (pmCS) recently identi-
fied from the serogroup F P. multocida strain P4679 (9).
The region 2 genes of the serogroup E cap locus demon-
strated a high level of similarity to those of serogroup B. The
deduced products of ecbI, ecbB, and ecbA were similar in
length and sequence (.92% identity) to their group B ho-
mologs (Table 4). Interestingly, there was no homolog of bcbH
within the serogroup E cap locus, in which ecbI is flanked by
lipA and ecbG. The sequence downstream of ecbB also differed
from its serogroup B homolog. Two ORFs, ecbJ and ecbK,
were identified that demonstrated little or no similarity to bcbC
(Table 5). The C-terminal amino acids of EcbJ showed low
levels of similarity to bacterial glycosyltransferases but no iden-
TABLE 2. Sequences of the oligonucleotides used in the P. multocida multiplex capsular PCR typing assay
Serogroup Gene Name Sequence (59339) Amplimersize (bp) Position
All KMT1 KMT1T7 ATCCGCTATTTACCCAGTGG 460
KMT1SP6 GCTGTAAACGAACTCGCCAC
A hyaD-hyaC CAPA-FWD TGCCAAAATCGCAGTCAG 1,044 8846–8863a
CAPA-REV TTGCCATCATTGTCAGTG 9890–9873
B bcbD CAPB-FWD CATTTATCCAAGCTCCACC 760 13621–13603b
CAPB-REV GCCCGAGAGTTTCAATCC 12863–12880
D dcbF CAPD-FWD TTACAAAAGAAAGACTAGGAGCCC 657 3142–3165c
CAPD-REV CATCTACCCACTCAACCATATCAG 3789–3766
E ecbJ CAPE-FWD TCCGCAGAAAATTATTGACTC 511 4387–4408d
CAPE-REV GCTTGCTGCTTGATTTTGTC 4899–4881
F fcbD CAPF-FWD AATCGGAGAACGCAGAAATCAG 851 2881–2896e
CAPF-REV TTCCGCCGTCAATTACTCTG 3733–3714
a These sequences match the coding strand of the serogroup A cap gene with GenBank accession number AF067175.
b These sequences match the coding strand of the serogroup B cap gene with GenBank accession number AF169324.
c These sequences match the coding strand of the serogroup D cap gene with GenBank accession number AF302465.
d These sequences match the coding strand of the serogroup E cap gene with GenBank accession number AF302466.
e These sequences match the coding strand of the serogroup F cap gene with GenBank accession number AF302467.
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tity to any proteins encoded by the serogroup B cap locus,
while the C terminus of EcbK was 55% similarity to BcbC. The
remaining four ORFs within region 2 of the serogroup E cap
locus (ecbDEFG) were shown to possess between 44 and 89%
similarities to their serogroup B homologs, bcbDEFG (Table 4).
Development of a multiplex capsular PCR typing assay for
P. multocida. It was evident from the comparative analyses that
sequences within hyaD, bcbD, dcbF, ecbJ, and fcbD were highly
specific for their respective serogroups. As serogroups D and F
possessed homologs of hyaB, hyaC, and, to some extent, hyaE,
glycosyltransferase genes hyaD, dcbF, and fcbD represented
potential serogroup-specific target sequences. The majority
of the region 2 genes of serogroup E were similar to those of
serogroup B. However, the sequence of ecbJ showed little
similarity to sequences in GenBank and therefore represented
an ideal candidate for the identification of serogroup-specific
sequences. Primer sequences were then designed to generate
PCR products of unique size. P. multocida-specific primers
were also included as an internal control to confirm the species
identification. The resultant multiplex PCR was shown to be
highly specific among the reference capsular type strains, with
only the P. multocida-specific product and the respective cap-
sular serogroup-specific product being amplified (Fig. 2). The
multiplex PCR was also highly specific among the majority
of field isolates. However, there was some disparity between
PCR type and capsular serotype within the serogroup F
strains. Of the five strains previously identified as serogroup
F, only strains P4218 and P5084 produced the expected sero-
group F-specific PCR product. The remaining three strains
(strains P4988, P5184, and P5239) were typed as serogroup A
strains by the multiplex capsular PCR assay (Table 1). How-
ever, sequence analysis of the glycosyltransferase genes used
for the serogroup A- and F-specific primers indicated that the
FIG. 1. Genetic organization of region 2 of the capsule biosynthetic loci of representative isolates of the five P. multocida capsular serogroups
(serogroups A, B, D, E, and F). The cap loci are shown from the following strains: P. multocida A:1 strain X-73 (GenBank accession number
AF067175), B:2 strain M1404 (GenBank accession number AF169324), serogroup D strain P934 (GenBank accession number AF302465),
serogroup E strain P1234 (GenBank accession number AF302466), and F:3 strain P4218 (GenBank accession number AF302467). Numbers above
the boxes indicates the distance (in base pairs) between the last base of the preceeding gene and the first base of the next gene. Genes depicted
by boxes above the line are transcribed in the left-to-right direction, while those beneath the line are transcribed in the right-to-left direction. †,
percent identity at amino acid level to A:1 capsule biosynthetic locus; ‡, percent identity at amino acid level to B:2 capsule biosynthetic locus.
TABLE 3. Identity (similarity) between products of the region 2
capsule biosynthetic regions of P. multocida
capsular serogroups A, D, and F
Strain
(serogroup)
Protein name, protein length (amino acids); % identity
(similarity) to X-73 (A:1) homolog
X-73 (A:1) HyaB, 477 HyaC, 390 HyaD, 972 HyaE, 622














a Percent identity (similarity) to serogroup A X-73 homolog.
b This protein has ,20% identity to X-73 homolog.
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strains were serogroup A, in agreement with the multiplex
PCR result.
DISCUSSION
The identification and sequence analysis of the biosynthetic
locus of the capsule of an organism can lead to a greater
understanding of its capsular polysaccharide composition and
can provide a genetic basis for the serological differences ob-
served between strains. Sequence determination of the biosyn-
thetic locus of the P. multocida serogroup A capsule by Chung
et al. (7) identified components responsible for the synthesis of
hyaluronic acid, consistent with hyaluronic acid being the prin-
cipal component of the type A capsule. However, genetic anal-
ysis of the serogroup B biosynthetic locus revealed only three
gene products with similarity to proteins known to be involved
in polysaccharide biosynthesis, while six gene products had no
similarity to known proteins (1). The structure of the type B
capsule remains unknown. Until recently, very little was known
about the compositions of the serogroup D and F capsular
polysaccharides, with even less known about the serogroup E
capsular polysaccharide. Therefore, determination of the se-
quences of the region 2 genes of the remaining serogroups was
undertaken in order to gain information about the capsules of
serogroups D, E, and F. This region was highly conserved
between serogroups A, D, and F. Three of the four genes were
homologous, with the unique gene for each group encoding a
glycosyltransferase. The serogroup A (HyaD) and F (FcbD)
genes were shown to encode hyaluronan and chondroitin syn-
thases, respectively (8, 9). In serogroup D, this gene product
(DcbF) was similar to the glycosyltransferase KfiC from E. coli
K5 that is involved in the formation of a polysaccharide similar
to heparin. The genetic similarity between the capsular biosyn-
thetic regions of P. multocida serogroup D and E. coli K5 is
consistent with the possibility that the serogroup D capsule
contains heparin polymers, a proposal previously based on the
decapsulation of type D strains by heparinase III (11).
Determination of the nucleotide sequence of the serogroup
E biosynthesis region provided little information about the
capsular polysaccharide composition. Region 2 of serogroup E
contains nine genes, two of which showed similarity to genes
involved in polysaccharide biosynthesis. These two genes have
homologs in the P. multocida B:2 cap locus, indicating that
N-acetyl-D-mannosaminuronic acid is a component of both the
serogroup B and the serogroup E capsules. Of the remaining
seven genes, five have homologs in the B:2 cap locus but still
have no known function, one encodes a putative glycosyltrans-
ferase, and the other is unique to serogroup E. Definitive
assignment of function must await further analysis and will be
aided by the determination of the structures of the type B and
E capsules.
Comparative analysis of the five capsular biosynthetic re-
gions confirmed a genetic basis for the serological differences
FIG. 2. Multiplex capsular PCR typing system for P. multocida.
Whole-cell PCR was performed with type strains of each of the five
capsular serogroups. Lane Multi CAP, combined products from mul-
tiplex PCR of all five serogroups; lane N, a negative control; lanes A to
F, multiplex PCR products from strains X-73 (A:1), M1404 (B:2), P934
(D), P1234 (E), and P4218 (F:3), respectively; lane M, DNA molecular
size marker.
TABLE 4. Identity (similarity) between products of the region 2 capsule biosynthetic regions of P. multocida serogroups B and E
Strain (serogroup) Protein name, protein length (amino acids); % identity (similarity) to M1404 (B:2) homolog
M1404 (B:2) BcbI, 326 BcbH, 721 BcbG, 521 BcbF, 124 BcbE, 236 BcbD, 475 BcbC, 1,033 BcbB, 422 BcbA, 374














a Percent identity (similarity) to serogroup B M1404 homolog.
b This proteiin has ,20% identity to M1404 homolog.
TABLE 5. Predicted functions for region 2 genes of







dcbB 477 hyaB 98 (98) Glycosyltransferase
dcbC 390 hyaC 92 (96) UDP-glucose dehydrogenase
dcbF 501 (219) kfiC 34 (54) Glycosyltransferase
dcbE 603 (219) hyaE 36 (56) Unknown function, KfiB
homolog
fcbB 477 hyaB 98 (99) Glycosyltransferase
fcbC 390 hyaC 98 (98) UDP-glucose dehydrogenase
fcbD 965 (27) pmCS 82 (90) Glycosyltransferase
fcbE 622 hyaE 97 (97) Unknown function, KfiB
homolog
ecbA 374 bcbA (wecA) 97 (98) UDP-N-acetylglucosamine
2-epimerase
ecbB 424 (12) bcbB (wecB) 89 (92) UDP-N-acetyl-D-mannoasmi-
nuronic acid dehydrogenase
ecbJ 705 Glycosyl transferase (39),
unknown (59)
ecbK 400 39 bcbCc 38 (55) Unknown
ecbD 417 (267) bcbD 23 (44) Unknown
ecbE 228 (28) bcbE 65 (86) Unknown
ecbF 126 (12) bcbF 72 (89) Unknown
ecbG 527 (16) bcbG 71 (80) Unknown
ecbI 326 bcbI 87 (91) Unknown
a Predicted length of deduced protein (in amino acids [aa]), with differences in
size from that of the homolog given in parentheses.
b Percentage identity (similarity) of protein products.
c The product is 392 amino acids.
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observed between strains. By using these genetic differences,
we have developed a rational, DNA-based typing system for
P. multocida. The multiplex capsular PCR assay provides a
rapid and highly specific alternative to conventional capsular
serotyping. There are currently only two laboratories world-
wide that make and maintain the antisera required for capsular
typing. The assay described in this report can be performed
with suspected P. multocida colonies from primary isolation
plates, thus reducing the time required for culture preparation.
It is also highly specific for strains genetically capable of pro-
ducing a serogroup-specific capsule. Notably, the PCR-based
system was not affected by the geographical distribution of
isolates. For example, isolates classified as serogroup A by
conventional serotyping from Australia, Vietnam, and the
United States all produced the appropriate amplimer with the
serogroup A cap-specific primers. This assay will also help
clarify the distinction between strains from closely related se-
rogroups A and F. Indeed, the assay clearly identified three
strains as serogroup A that had previously been serotyped
erroneously as serogroup F, a finding confirmed by sequence
analysis of the cap locus. Serogroups A and F are now known
to have hyaluronic acid- and chondroitin-like polysaccharide
capsules, respectively. As these are both nonimmunogenic
polymers, it is unclear which antigens are responsible for the
capsule-specific reactions observed in the indirect hemaggluti-
nation test. Despite the lack of knowledge regarding the spe-
cific immunogens, capsular serotyping has provided a useful
system for P. multocida classification. However, with deter-
mination of the sequence of the cap locus in each serogroup,
we believe that genetic cap identification by PCR will become
a system for the rational and definitive typing of the P. multo-
cida capsule.
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